Innate Pharma (NasdaqGS:IPHA) Update / Briefing October 28, 2025 08:00 AM ET Speaker0We're very excited to be here this morning. We have, from an eight pharma perspective, our lacutamab KOL event, where we will be reviewing the clinical perspectives and the commercial outlook for lacutamab. I'm very excited that we have over 100 people joining us this morning online and here in the room in New York City. So we will be making some forward looking statements.So we have our standard disclosure statement here. ...